meropenem; EUCAST; severe infections; targeted AST reporting
Abstract :
[en] The 2020 EUCAST criteria increased meropenem use for P. aeruginosa monobacterial infections in Belgium. While severe infections and allergies
to first-line antipseudomonals partly explain this increase, the findings emphasize selective AST reporting's role in reducing use and the need for
prescriber education before major practice changes. Targeted stewardship programs can promote appropriate antimicrobial use.
Disciplines :
Immunology & infectious disease
Author, co-author :
Catteau, L.
LAYIOS, Nathalie ; Centre Hospitalier Universitaire de Liège - CHU > > Service des soins intensifs
Meex, Cécile ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Bactériologie, mycologie, parasitologie, virologie et microbiologie
